Literature DB >> 33741997

Unmapped exome reads implicate a role for Anelloviridae in childhood HIV-1 long-term non-progression.

Savannah Mwesigwa1, Lesedi Williams2, Gaone Retshabile2, Eric Katagirya1, Gerald Mboowa1, Busisiwe Mlotshwa2, Samuel Kyobe1, David P Kateete1, Eddie Mujjwiga Wampande1, Misaki Wayengera1, Sununguko Wata Mpoloka2, Angella N Mirembe3, Ishmael Kasvosve2, Koketso Morapedi2, Grace P Kisitu3, Adeodata R Kekitiinwa3, Gabriel Anabwani4, Moses L Joloba1, Enock Matovu5, Julius Mulindwa5, Harry Noyes6, Gerrit Botha7, Chester W Brown8, Graeme Mardon9, Mogomotsi Matshaba4,9, Neil A Hanchard10,11.   

Abstract

Human immunodeficiency virus (HIV) infection remains a significant public health burden globally. The role of viral co-infection in the rate of progression of HIV infection has been suggested but not empirically tested, particularly among children. We extracted and classified 42 viral species from whole-exome sequencing (WES) data of 813 HIV-infected children in Botswana and Uganda categorised as either long-term non-progressors (LTNPs) or rapid progressors (RPs). The Ugandan participants had a higher viral community diversity index compared to Batswana (p = 4.6 × 10-13), and viral sequences were more frequently detected among LTNPs than RPs (24% vs 16%; p = 0.008; OR, 1.9; 95% CI, 1.6-2.3), with Anelloviridae showing strong association with LTNP status (p = 3 × 10-4; q = 0.004, OR, 3.99; 95% CI, 1.74-10.25). This trend was still evident when stratified by country, sex, and sequencing platform, and after a logistic regression analysis adjusting for age, sex, country, and the sequencing platform (p = 0.02; q = 0.03; OR, 7.3; 95% CI, 1.6-40.5). Torque teno virus (TTV), which made up 95% of the Anelloviridae reads, has been associated with reduced immune activation. We identify an association between viral co-infection and prolonged AIDs-free survival status that may have utility as a biomarker of LTNP and could provide mechanistic insights to HIV progression in children, demonstrating the added value of interrogating off-target WES reads in cohort studies.

Entities:  

Year:  2021        PMID: 33741997      PMCID: PMC7979878          DOI: 10.1038/s41525-021-00185-w

Source DB:  PubMed          Journal:  NPJ Genom Med        ISSN: 2056-7944            Impact factor:   8.617


  86 in total

Review 1.  The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS.

Authors:  Anthony Wood; Duncan Armour
Journal:  Prog Med Chem       Date:  2005

2.  Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy.

Authors:  G McMichael; M N Bainbridge; E Haan; M Corbett; A Gardner; S Thompson; B W M van Bon; C L van Eyk; J Broadbent; C Reynolds; M E O'Callaghan; L S Nguyen; D L Adelson; R Russo; S Jhangiani; H Doddapaneni; D M Muzny; R A Gibbs; J Gecz; A H MacLennan
Journal:  Mol Psychiatry       Date:  2015-02-10       Impact factor: 15.992

3.  A test for comparing diversities based on the Shannon formula.

Authors:  K Hutcheson
Journal:  J Theor Biol       Date:  1970-10       Impact factor: 2.691

4.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

5.  Exome sequencing generates high quality data in non-target regions.

Authors:  Yan Guo; Jirong Long; Jing He; Chung-I Li; Qiuyin Cai; Xiao-Ou Shu; Wei Zheng; Chun Li
Journal:  BMC Genomics       Date:  2012-05-20       Impact factor: 3.969

6.  A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.

Authors:  Michael J Strong; Eugene Blanchard; Zhen Lin; Cindy A Morris; Melody Baddoo; Christopher M Taylor; Marcus L Ware; Erik K Flemington
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

7.  Exome sequencing reveals novel genetic loci influencing obesity-related traits in Hispanic children.

Authors:  Aniko Sabo; Pamela Mishra; Shannon Dugan-Perez; V Saroja Voruganti; Jack W Kent; Divya Kalra; Shelley A Cole; Anthony G Comuzzie; Donna M Muzny; Richard A Gibbs; Nancy F Butte
Journal:  Obesity (Silver Spring)       Date:  2017-05-16       Impact factor: 5.002

8.  The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa.

Authors:  Gerald Mboowa; Savannah Mwesigwa; Eric Katagirya; Gaone Retshabile; Busisiwe C Mlotshwa; Lesedi Williams; Adeodata Kekitiinwa; David Kateete; Eddie Wampande; Misaki Wayengera; Betty Nsangi Kintu; Grace P Kisitu; Samuel Kyobe; Chester W Brown; Neil A Hanchard; Graeme Mardon; Moses Joloba; Gabriel Anabwani; Ed Pettitt; Masego Tsimako-Johnstone; Ishmael Kasvosve; Koketso Maplanka; Sununguko W Mpoloka; Makhosazana Hlatshwayo; Mogomotsi Matshaba
Journal:  AAS Open Res       Date:  2018-04-18

9.  VirusFinder: software for efficient and accurate detection of viruses and their integration sites in host genomes through next generation sequencing data.

Authors:  Qingguo Wang; Peilin Jia; Zhongming Zhao
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

10.  High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation.

Authors:  Julius Mulindwa; Harry Noyes; Hamidou Ilboudo; Luca Pagani; Oscar Nyangiri; Magambo Phillip Kimuda; Bernardin Ahouty; Olivier Fataki Asina; Elvis Ofon; Kelita Kamoto; Justin Windingoudi Kabore; Mathurin Koffi; Dieudonne Mumba Ngoyi; Gustave Simo; John Chisi; Issa Sidibe; John Enyaru; Martin Simuunza; Pius Alibu; Vincent Jamonneau; Mamadou Camara; Andy Tait; Neil Hall; Bruno Bucheton; Annette MacLeod; Christiane Hertz-Fowler; Enock Matovu
Journal:  Am J Hum Genet       Date:  2020-08-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.